Cite
Medicinal chemistry strategies for the development of protein tyrosine phosphatase SHP2 inhibitors and PROTAC degraders.
MLA
Tang, Kai, et al. “Medicinal Chemistry Strategies for the Development of Protein Tyrosine Phosphatase SHP2 Inhibitors and PROTAC Degraders.” European Journal of Medicinal Chemistry, vol. 204, Oct. 2020, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.ejmech.2020.112657.
APA
Tang, K., Jia, Y.-N., Yu, B., & Liu, H.-M. (2020). Medicinal chemistry strategies for the development of protein tyrosine phosphatase SHP2 inhibitors and PROTAC degraders. European Journal of Medicinal Chemistry, 204, N.PAG. https://doi.org/10.1016/j.ejmech.2020.112657
Chicago
Tang, Kai, Yao-Nan Jia, Bin Yu, and Hong-Min Liu. 2020. “Medicinal Chemistry Strategies for the Development of Protein Tyrosine Phosphatase SHP2 Inhibitors and PROTAC Degraders.” European Journal of Medicinal Chemistry 204 (October): N.PAG. doi:10.1016/j.ejmech.2020.112657.